S100B and Stroke: High S100β levels (>0.23 g/L) in blood in ischemic stroke patients are associated with a higher risk of hemorrhagic transformation after thrombolysis treatment (82), which makes this protein of great interest for informing clinical decision-making after stroke, even though further studies are needed.